Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity
The lipid composition of the plasma membrane defines the localisation of KRAS and its oncogenic function. Here the authors show that EFR3A binds to active KRAS to recruit PI4KA and alters the lipid composition of the plasma membrane to promote KRAS oncogenic signalling and tumorigenesis.
Enregistré dans:
Auteurs principaux: | Hema Adhikari, Walaa E. Kattan, Shivesh Kumar, Pei Zhou, John F. Hancock, Christopher M. Counter |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b15aa2d411704499ade6c2c0e8aff6f3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability
par: Hema Adhikari, et autres
Publié: (2018) -
Oncogenic KRAS: Signaling and Drug Resistance
par: Hyeon Jin Kim, et autres
Publié: (2021) -
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
par: Nicolas Bery, et autres
Publié: (2020) -
Immune modulatory effects of oncogenic KRAS in cancer
par: Shaima’a Hamarsheh, et autres
Publié: (2020) -
Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis
par: Liu X, et autres
Publié: (2019)